TechCrunch Disrupt 2025 has issued a final call for startups, with only two days remaining to secure an exhibition presence at the world’s most influential technology summit. Brands seeking to capitalize on high-intent investor interest…
Eyebot, a medical technology pioneer, secured a $20 million Series A funding round led by General Catalyst to accelerate the nationwide deployment of its automated vision testing kiosks. This capital injection enables the startup to…
Amazon Web Services (AWS) has expanded its Amazon Connect Health ecosystem by launching a specialized AI agent platform designed to automate administrative tasks and alleviate the growing burden of burnout among medical professionals. This strategic…
Former Zomato CEO Deepinder Goyal has raised $54 million in a fresh funding round for his new wearable startup, Temple, signaling a strategic pivot toward high-stakes neurotechnology and elite performance optimization. The capital injection, structured…
Verily, Alphabet’s life sciences division, shuttered its medical hardware program and laid off staff on Monday as the company reallocates resources to dominate the AI and data infrastructure sectors. CEO Stephen Gillett Cites AI Infrastructure…
Former X CEO Linda Yaccarino has been appointed as the new Chief Executive Officer of eMed Population Health, an AI-driven startup pivoting its technology toward the rapidly expanding GLP-1 weight-loss medication market. The move marks…
Oxford University spinout RADiCAIT is disrupting the oncology landscape by deploying synthetic PET images that deliver the same diagnostic precision as traditional chemical scans, potentially eliminating the need for expensive radioactive tracers in cancer monitoring.…
TechCrunch Disrupt 2025 officially closes its exhibition registration today, marking the final opportunity for startups to secure a physical footprint at San Francisco’s Moscone West from October 27–29. This deadline serves as the last call…
Evan Kervella, CEO of Paris-based startup Chipiron, outlined a transformative vision to decentralize Magnetic Resonance Imaging (MRI) technology during an appearance on TechCrunch’s flagship podcast, Equity, as medical device funding returns to 2021 highs. A…
Billionaire investor Mark Cuban is aggressively dismantling the $5 trillion American healthcare machine through his venture, Cost Plus Drugs, by bypassing traditional middlemen to provide transparent pricing for essential medications. Speaking on a recent episode…
